Updated Jul 16, 2026
Berard Todd has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $315K.

Todd Berard is the Chief Marketing Officer at BioLife Solutions Inc, a company specializing in bioproduction products and services for the cell and gene therapy industry. He has been involved in multiple SEC filings related to his role at the company.
| Role | Chief Marketing Officer |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | BLFS | BIOLIFE SOLUTIONS INC | F — Tax withholding / forfeiture | 293 | $27.79 | $8K |
| 2026-06-22 | BLFS | BIOLIFE SOLUTIONS INC | F — Tax withholding / forfeiture | 470 | $26.04 | $12K |
| 2026-06-10 | BLFS | BIOLIFE SOLUTIONS INC | F — Tax withholding / forfeiture | 356 | $26.10 | $9K |
| 2026-04-10 | BLFS | BIOLIFE SOLUTIONS INC | F — Tax withholding / forfeiture | 293 | $19.27 | $6K |
| 2026-03-23 | BLFS | BIOLIFE SOLUTIONS INC | F — Tax withholding / forfeiture | 1.9K | $19.12 | $36K |
| 2026-03-05 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale [10b5-1] | 353 | $20.74 | $7K |
| 2026-02-26 | BLFS | BIOLIFE SOLUTIONS INC | F — Tax withholding / forfeiture | 8.8K | $22.65 | $200K |
| 2026-02-26 | BLFS | BIOLIFE SOLUTIONS INC | A — Grant or award | 22.5K | — | |
| 2026-02-26 | BLFS | BIOLIFE SOLUTIONS INC | A — Grant or award | 20.1K | — | |
| 2025-10-09 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale | 289 | $27.36 | $8K |
| 2025-09-11 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale | 358 | $26.83 | $10K |
| 2025-08-26 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale | 354 | $25.44 | $9K |
| 2025-08-25 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale | 10.0K | $25.53 | $255K |
| 2025-07-07 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale | 304 | $22.27 | $7K |
| 2024-11-29 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale [10b5-1] | 349 | $27.20 | $9K |
| 2024-11-14 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale [10b5-1] | 91 | $26.34 | $2K |
| 2024-11-01 | BLFS | BIOLIFE SOLUTIONS INC | S — Open-market sale [10b5-1] | 311 | $23.15 | $7K |
Todd Berard is the Chief Marketing Officer at BioLife Solutions Inc, a company specializing in bioproduction products and services for the cell and gene therapy industry. He has been involved in multiple SEC filings related to his role at the company.…
3 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 9 open-market sales ($315K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Berard Todd profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.